SK
Subbarao Kattamuri
About Subbarao Kattamuri
Data last updated:
Subbarao Kattamuri is a Director at Priche Generics Private Limited (since 2016), Managing Director at Evertogen Life Sciences Limited (since 2013) and Director at Lytica Labs Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹186 Cr; the largest is Priche Generics Private Limited at ₹96.36 Cr (FY 2025). Earlier, Subbarao Kattamuri was a Director at Glochem Industries Private Limited (2020–2025) and Director at Gil Agrotech ( India ) Private Limited (from 2010) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Oct 2016 | 2016 | ₹96.36 Cr (FY 2025) | Active | |
| Managing Director | 11 Jan 2013 | 2013 | ₹89.28 Cr (FY 2024) | Active | |
| Director | 01 Dec 2017 | 2017 | ₹13.5 Lakh (FY 2025) | Active | |
| Director | 08 Jul 2015 | 2002 | ₹6.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Nov 2020 | 2020 | ₹114 Cr (FY 2025) | Active | |
| Director | 20 Jul 2010 | 2010 | Amalgamated | ||
| Managing Director | 01 Jul 2011 | 1995 | ₹58.99 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Subbarao Kattamuri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sushma Kattamuri | 02986836 | Priche Generics Private Limited , Evertogen Life Sciences Limited and 2 more | Director |
| Akhila Thotapally | Evertogen Life Sciences Limited | Company Secretary | |
| Manav Jassal | 03059931 | Evertogen Life Sciences Limited | Director |
| Sat Paul Jassal | 07329650 | Evertogen Life Sciences Limited | Director |
| Sherifuddin Sheriff Shaik | 02201440 | Evertogen Life Sciences Limited | Director |
| Vikram Ravindra Mamidipudi | 00008241 | Evertogen Life Sciences Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subbarao Kattamuri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subbarao Kattamuri
Subbarao Kattamuri currently holds 4 directorships: Priche Generics Private Limited (Director, since 04 Oct 2016, revenue ₹96.36 Cr (FY 2025)); Evertogen Life Sciences Limited (Managing Director, since 11 Jan 2013, revenue ₹89.28 Cr (FY 2024)); Lytica Labs Private Limited (Director, since 01 Dec 2017, revenue ₹13.5 Lakh (FY 2025)); K.R.R. Drugs & Intermediates Private Limited (Director, since 08 Jul 2015, revenue ₹6.3 Lakh (FY 2025)).
Subbarao Kattamuri was first appointed on 20 Jul 2010 as Director at Gil Agrotech ( India ) Private Limited. The most recent appointment on record is 24 Nov 2020 at Glochem Industries Private Limited.
The 4 current companies of Subbarao Kattamuri that report revenue have a combined latest revenue of ₹186 Cr: Priche Generics Private Limited ₹96.36 Cr (FY 2025); Evertogen Life Sciences Limited ₹89.28 Cr (FY 2024); Lytica Labs Private Limited ₹13.5 Lakh (FY 2025); K.R.R. Drugs & Intermediates Private Limited ₹6.3 Lakh (FY 2025).
Subbarao Kattamuri held 3 earlier board appointments: Glochem Industries Private Limited (Director, 24 Nov 2020 to 14 Aug 2025); Gil Agrotech ( India ) Private Limited (Director, from 20 Jul 2010); Glochem Industries Private Limited (Managing Director, from 01 Jul 2011).
The current boards of Subbarao Kattamuri's companies include Sushma Kattamuri (Priche Generics Private Limited), Akhila Thotapally (Evertogen Life Sciences Limited), Manav Jassal (Evertogen Life Sciences Limited), Sat Paul Jassal (Evertogen Life Sciences Limited), Sherifuddin Sheriff Shaik (Evertogen Life Sciences Limited), Vikram Ravindra Mamidipudi (Evertogen Life Sciences Limited).